{"entity":{"type":"insider","cik":"0001289797","url":"/insider/0001289797","json_url":"/insider/0001289797.json","name":"Burgoon Richard Jr","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":16,"first":"2005-04-04","last":"2005-09-02","span_basis":"filed_date"},"name_variants":[{"name":"Burgoon Richard Jr","source":"filing","n_filings":16,"first_seen":"2005-04-04","last_seen":"2005-09-02"}],"transactions":[{"id":1380546,"accession":"0001223692-05-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-05-000033","line_url":"/filing/0001223692-05-000033#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":1260.0,"total_display":"1,260.00","shares_owned_after":60916.0,"shares_owned_after_display":"60,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-02","filed_date":"2005-09-02","scope":"insider"},{"id":1380545,"accession":"0001223692-05-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000033","line_url":"/filing/0001223692-05-000033#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":190.0,"total_display":"190.00","shares_owned_after":59516.0,"shares_owned_after_display":"59,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-01","filed_date":"2005-09-02","scope":"insider"},{"id":1355459,"accession":"0001223692-05-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000032","line_url":"/filing/0001223692-05-000032#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","shares_owned_after":59316.0,"shares_owned_after_display":"59,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-30","filed_date":"2005-08-30","scope":"insider"},{"id":1232686,"accession":"0001223692-05-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000030","line_url":"/filing/0001223692-05-000030#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":340.0,"total_display":"340.00","shares_owned_after":58066.0,"shares_owned_after_display":"58,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-29","filed_date":"2005-08-29","scope":"insider"},{"id":1498725,"accession":"0001223692-05-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000029","line_url":"/filing/0001223692-05-000029#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":184.0,"total_display":"184.00","shares_owned_after":57666.0,"shares_owned_after_display":"57,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-23","filed_date":"2005-08-26","scope":"insider"},{"id":1612794,"accession":"0001223692-05-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000026","line_url":"/filing/0001223692-05-000026#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":291.0,"total_display":"291.00","shares_owned_after":57466.0,"shares_owned_after_display":"57,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-17","filed_date":"2005-08-18","scope":"insider"},{"id":1429206,"accession":"0001223692-05-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000025","line_url":"/filing/0001223692-05-000025#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":291.0,"total_display":"291.00","shares_owned_after":57166.0,"shares_owned_after_display":"57,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-12","filed_date":"2005-08-12","scope":"insider"},{"id":1434223,"accession":"0001223692-05-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000019","line_url":"/filing/0001223692-05-000019#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":291.0,"total_display":"291.00","shares_owned_after":56866.0,"shares_owned_after_display":"56,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-01","filed_date":"2005-08-01","scope":"insider"},{"id":1240289,"accession":"0001223692-05-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-05-000018","line_url":"/filing/0001223692-05-000018#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":291.0,"total_display":"291.00","shares_owned_after":56566.0,"shares_owned_after_display":"56,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-29","filed_date":"2005-07-29","scope":"insider"},{"id":1240288,"accession":"0001223692-05-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000018","line_url":"/filing/0001223692-05-000018#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":97.0,"total_display":"97.00","shares_owned_after":56266.0,"shares_owned_after_display":"56,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-28","filed_date":"2005-07-29","scope":"insider"},{"id":1490497,"accession":"0001223692-05-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000017","line_url":"/filing/0001223692-05-000017#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":97.0,"total_display":"97.00","shares_owned_after":56166.0,"shares_owned_after_display":"56,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-25","filed_date":"2005-07-26","scope":"insider"},{"id":1364418,"accession":"0001223692-05-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000016","line_url":"/filing/0001223692-05-000016#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":194.0,"total_display":"194.00","shares_owned_after":56066.0,"shares_owned_after_display":"56,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-22","filed_date":"2005-07-25","scope":"insider"},{"id":1425027,"accession":"0001223692-05-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000014","line_url":"/filing/0001223692-05-000014#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":291.0,"total_display":"291.00","shares_owned_after":55866.0,"shares_owned_after_display":"55,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-21","filed_date":"2005-07-21","scope":"insider"},{"id":1236925,"accession":"0001223692-05-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000013","line_url":"/filing/0001223692-05-000013#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":194.0,"total_display":"194.00","shares_owned_after":55566.0,"shares_owned_after_display":"55,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1458542,"accession":"0001223692-05-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-05-000009","line_url":"/filing/0001223692-05-000009#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":194.0,"total_display":"194.00","shares_owned_after":13700.0,"shares_owned_after_display":"13,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-19","filed_date":"2005-07-20","scope":"insider"},{"id":1458541,"accession":"0001223692-05-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000009","line_url":"/filing/0001223692-05-000009#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":194.0,"total_display":"194.00","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-18","filed_date":"2005-07-20","scope":"insider"},{"id":1626304,"accession":"0001223692-05-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-05-000007","line_url":"/filing/0001223692-05-000007#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":388.0,"total_display":"388.00","shares_owned_after":13300.0,"shares_owned_after_display":"13,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-14","filed_date":"2005-07-15","scope":"insider"},{"id":1626303,"accession":"0001223692-05-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-05-000007","line_url":"/filing/0001223692-05-000007#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":194.0,"total_display":"194.00","shares_owned_after":12900.0,"shares_owned_after_display":"12,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-13","filed_date":"2005-07-15","scope":"insider"},{"id":1359444,"accession":"0001187233-05-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001187233-05-000011","line_url":"/filing/0001187233-05-000011#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":1020.0,"total_display":"1,020.00","shares_owned_after":12700.0,"shares_owned_after_display":"12,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-20","filed_date":"2005-04-21","scope":"insider"},{"id":1359443,"accession":"0001187233-05-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001187233-05-000011","line_url":"/filing/0001187233-05-000011#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":2320.0,"total_display":"2,320.00","shares_owned_after":10700.0,"shares_owned_after_display":"10,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-14","filed_date":"2005-04-21","scope":"insider"},{"id":1440722,"accession":"0001187233-05-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001187233-05-000010","line_url":"/filing/0001187233-05-000010#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289797","owner_name":"Burgoon Richard Jr","owner_url":"/insider/0001289797","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6700.0,"shares_display":"6,700","price_per_share":0.6933,"price_display":"0.69","price_state":"stated","total_value":4645.11,"total_display":"4,645.11","shares_owned_after":6700.0,"shares_owned_after_display":"6,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-31","filed_date":"2005-04-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001261734","name":"AEOLUS PHARMACEUTICALS, INC.","url":"/issuer/0001261734","role":"Officer (Chief Executive Officer)","n_filings":16,"first_seen":"2005-04-04","last_seen":"2005-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001289797","retrieved_at":"2026-08-21T19:56:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}